Author:
Watanabe Naoki,Yuasa Takeshi,Shimada Ken
Reference39 articles.
1. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer. 2003;97:2869-2879
2. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management. Journal of the American College of Cardiology. 2009;53:2231-2247
3. Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, et al. Risk factors for doxorubicin-induced congestive heart failure. Annals of Internal Medicine. 1979;91:710-717
4. Gradishar WJ, Anderson BO, Balassanlan R, et al. NCCN clinical practice guidelines in oncology. Breast Cancer. 2018;2018
5. Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochimica et Biophysica Acta. 1994;1198:165-184
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献